Thema
Journal Article
15
Case Reports
6
Randomized Controlled Trial
5
Research Support, Non-U.S. Gov't
5
31YO63LBSN
3
Clinical Trial, Phase III
3
Multicenter Study
3
Nivolumab
3
Antibodies, Monoclonal, Humanized
2
BRCA1 Protein
2
BRCA1 protein, human
2
BRCA1/2
2
BRCA2 Protein
2
BRCA2 protein, human
2
COVID-19
2
Comparative Study
2
DPT0O3T46P
2
pembrolizumab
2
3Z8479ZZ5X
1
570
1
80168379AG
1
8N3DW7272P
1
Afro-Colombian
1
Afro‐Colombians
1
Antineoplastic Agents, Immunological
1
B7-H1 Antigen
1
BG3F62OND5
1
Biology
1
Biomarkers, Tumor
1
Breast neoplasms
1
Cancer
1
Carboplatin
1
Colombia
1
Core Binding Factor Alpha 1 Subunit
1
Cyclophosphamide
1
DNA, Neoplasm
1
Doxorubicin
1
EC 2.7.10.1
1
EC 3.6.5.2
1
EGFR protein, human
1
Epirubicin
1
ErbB Receptors
1
Founder mutations
1
Hereditary breast cancer
1
Immune Checkpoint Inhibitors
1
Ipilimumab
1
KRAS protein, human
1
Latin American country
1
Mortality
1
Neurofibrosarcoma
1
mehr ...